DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,849,000 | +27.1% | 91,733 | +135.3% | 0.00% | 0.0% |
| Q2 2021 | $1,455,000 | -16.2% | 38,992 | -42.6% | 0.00% | 0.0% |
| Q1 2021 | $1,736,000 | +35.2% | 67,873 | +16.4% | 0.00% | +50.0% |
| Q4 2020 | $1,284,000 | -35.3% | 58,306 | -47.2% | 0.00% | -33.3% |
| Q3 2020 | $1,985,000 | -40.3% | 110,366 | -15.7% | 0.00% | -40.0% |
| Q2 2020 | $3,326,000 | +42.2% | 130,943 | +2.8% | 0.01% | +25.0% |
| Q1 2020 | $2,339,000 | +429.2% | 127,331 | +534.2% | 0.00% | +300.0% |
| Q4 2019 | $442,000 | +74.0% | 20,079 | +13.4% | 0.00% | – |
| Q3 2019 | $254,000 | -59.3% | 17,707 | -55.3% | 0.00% | -100.0% |
| Q2 2019 | $624,000 | +19.3% | 39,643 | +11.0% | 0.00% | 0.0% |
| Q1 2019 | $523,000 | -2.8% | 35,724 | -29.0% | 0.00% | 0.0% |
| Q4 2018 | $538,000 | -20.2% | 50,281 | +13.9% | 0.00% | 0.0% |
| Q3 2018 | $674,000 | +27.4% | 44,161 | +2.3% | 0.00% | 0.0% |
| Q2 2018 | $529,000 | +136.2% | 43,178 | +3.4% | 0.00% | – |
| Q1 2016 | $224,000 | -79.6% | 41,758 | -54.8% | 0.00% | -100.0% |
| Q4 2015 | $1,097,000 | +74.1% | 92,440 | +20.6% | 0.00% | +100.0% |
| Q3 2015 | $630,000 | +1.6% | 76,678 | +72.5% | 0.00% | 0.0% |
| Q2 2015 | $620,000 | – | 44,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|